A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Ipsen
PharmaMar
Columbia University
Ipsen
Masonic Cancer Center, University of Minnesota
Novartis
Stanford University
Valerio Therapeutics
Valerio Therapeutics
Astellas Pharma Inc